GE HealthCare Technologies Inc

For the period ended Mar 31, 2024. Filed Apr 30, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed Apr 30, 2024

GEHC$83.65-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

Condensed Consolidated Statements of Income (Unaudited)
	For the three months ended March 31
(In millions, except per share amounts)	2024	2023
Sales of products	$3,045	$3,131
Sales of services	1,605	1,576
Total revenues	4,650	4,707
Cost of products	1,967	2,037
Cost of services	782	779
Gross profit	1,902	1,891
Selling, general, and administrative	1,038	1,062
Research and development	324	270
Total operating expenses	1,362	1,332
Operating income	540	559
Interest and other financial charges – net	122	136
Non-operating benefit (income) costs	(102)	(115)
Other (income) expense – net	8	(8)
Income before income taxes	512	546
Benefit (provision) for income taxes	(124)	(163)
Net income	388	383
Net (income) loss attributable to noncontrolling interests	(14)	(11)
Net income attributable to GE HealthCare	374	372
Deemed preferred stock dividend of redeemable noncontrolling interest	—	(183)
Net income attributable to GE HealthCare common stockholders	$374	$189
Earnings per share attributable to GE HealthCare common stockholders:
Basic	$0.82	$0.42
Diluted	$0.81	$0.41
Weighted-average number of shares outstanding:
Basic	456	454
Diluted	459	457

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.